Home >
News >
#ESHCML2024 REMINDER: ABSTRACT SUBMISSION & SCHOLARSHIP APPLICATIONS ARE OPEN!
#ESHCML2024 REMINDER: ABSTRACT SUBMISSION & SCHOLARSHIP APPLICATIONS ARE OPEN!
April 12, 2024
26th Annual John Goldman Conference on
CHRONIC MYELOID LEUKEMIA:
Biology and Therapy
September 27-29, 2024
Prague, Czech Republic
#ESHCML2024
Chairpersons: Jorge Cortes, Tim P. Hughes, Daniela S. Krause
Co-organizers: Ravi Bhatia, Tim Brümmendorf, Mhairi Copland, Michael Deininger, Oliver Hantschel, Vignir Helgason, Sin Tiong Ong, Jerry Radich, Delphine Réa
Advisory Committee: Jane Apperley, Susan Branford, Carlo Gambacorti-Passerini, François Guilhot, Rüdiger Hehlmann, Pierre Laneuville, François-Xavier Mahon, Danilo Perrotti, Giuseppe Saglio, Charles Schiffer, Simona Soverini, Peter Valent, Rick Van Etten
The deadline for abstract submission is approaching: May 8th, 2024
DON'T DELAY:
Abstracts are eligible to be selected for
Brief Oral Communications or Poster Presentations.
REMINDER:
LEUKAEMIA UK INTERNATIONAL SCHOLARSHIP FUNDS
This Call for Applications is made thanks to funding support from:
The present Call for Applications may be of interest to you if you are:
- Fully trained, with a maximum of 4 years experience since your first junior faculty appointment
- A Resident or PhD candidate
Deadline for applications: May 8th, 2024
7 early-career biologists and clinicians attended
the 2023 John Goldman Conference on CML
thanks to support from Leukaemia UK.
The ESH Scholarship Fund is a multi-sponsored project designed to support access to new biological and clinical data in the context of lifelong learning in Haematology.
- ESH independently ensures all scientific peer review and selection procedures.
- ESH is also independently responsible for all administrative aspects of the Fund.
ABOUT THE JOHN GOLDMAN CONFERENCE:
The meeting brings together experts in CML research and practice from all over the world, giving the opportunities to all attendees to interact, exchange ideas, review the most recent research and future plans for additional studies. The open interaction format provides an excellent forum to encourage collaborations and open discussion.
MORE INFORMATION
